Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Location: New York NY, Rochester NY, Charleston SC, Tampa FL,
Sponsor: Liquidia Technologies, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07285655

Phase 3, Recruiting

Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease

for
COPD, Pulmonary Hypertension, Exercise,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 40+

Code: NCT07576894

Recruiting

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

for
Bronchopulmonary Dysplasia, Pulmonary Hypertension
Location: New Haven CT, Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 0

Code: NCT06373289

Recruiting

Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)

for
Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia,
Location: Miami FL
Sponsor: Rodrigo Ruano

Sex: Female

Age: 18 - 50

Code: NCT03138863

Recruiting

Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

for
Hypotension and Shock,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 0

Code: NCT07322133

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pulmonary Hypertension (PH) Biorepository for Translational Research

for
Pulmonary Hypertension
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)

Sex: All

Age: 18 - 70+

Code: NCT07647549

Recruiting

Early Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH)

for
Pulmonary Hypertension
Location: Paramus NJ
Sponsor: Valley Health System

Sex: All

Age: 18+

Code: NCT07837830

Early Phase 1, Recruiting

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension, Interstitial Lung Disease
Location: New York NY, Philadelphia PA, Richmond VA, Durham NC,
Sponsor: Insmed Incorporated

Sex: All

Age: 18+

Code: NCT07179380

Phase 3, Recruiting

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

for
Pulmonary Hypertension, Congestive Heart Failure(CHF),
Location: Boulder CO
Sponsor: HemoCept Inc.

Sex: All

Age: 18+

Code: NCT07224906

Recruiting

HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction

for
Pulmonary Hypertension,
Location: Greenville SC, Kansas City MO, Dallas TX
Sponsor: 35Pharma Inc., a GSK company

Sex: All

Age: 18+

Code: NCT07123779

Phase 1, Phase 2, Recruiting

Sotatercept in Pulmonary Arterial Hypertension

for
Pulmonary Artery Hypertension
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT07140484

Phase 4, Recruiting

Safety and Efficacy of FETO in CDH Phase III

for
Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: Female

Age: 18 - 50

Code: NCT07187206

Phase 3, Recruiting

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

for
Pulmonary Hypertension
Location: Providence RI, Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT07132788

Recruiting

Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension

for
Pulmonary Hypertension
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18 - 70+

Code: NCT07563322

Recruiting

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension (PAH)
Location: Boston MA, Cincinnati OH, Omaha NE, Aurora CO
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318597

Phase 2, Recruiting

Real World Observational Study of Sotatercept for Pulmonary Hypertension

for
Pulmonary Hypertension
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06751082

Recruiting

Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

for
Pulmonary Hypertension
Location: Providence RI
Sponsor: Eko Devices, Inc.

Sex: All

Age: 18+

Code: NCT05873387

Recruiting

Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope

for
Pulmnary Hypertension
Location: Los Angeles CA
Sponsor: Eko Devices, Inc.

Sex: All

Age: 18+

Code: NCT07136623

Recruiting

Bioenergetic Effect of Pioglitazone in CLD-PH

for
Pulmonary Hypertension,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06336798

Phase 2, Recruiting

Pulmonary Hypertension in Left Heart Disease

for
Pulmonary Hypertension, Pulmonary Vascular Disease,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05935605

Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial